Amicus Therapeutics Inc (FOLD)
10.61
+0.27
(+2.61%)
USD |
NASDAQ |
Apr 19, 16:00
10.61
0.00 (0.00%)
After-Hours: 16:52
Amicus Therapeutics Cash from Operations (TTM): -69.09M for Dec. 31, 2023
Cash from Operations (TTM) Chart
Historical Cash from Operations (TTM) Data
Date | Value |
---|---|
December 31, 2023 | -69.09M |
September 30, 2023 | -153.32M |
June 30, 2023 | -126.60M |
March 31, 2023 | -126.33M |
December 31, 2022 | -166.58M |
September 30, 2022 | -156.32M |
June 30, 2022 | -168.39M |
March 31, 2022 | -188.45M |
December 31, 2021 | -202.49M |
September 30, 2021 | -181.80M |
June 30, 2021 | -200.11M |
March 31, 2021 | -197.70M |
December 31, 2020 | -233.29M |
September 30, 2020 | -241.30M |
June 30, 2020 | -254.84M |
March 31, 2020 | -279.81M |
December 31, 2019 | -250.42M |
September 30, 2019 | -253.26M |
June 30, 2019 | -330.47M |
March 31, 2019 | -328.98M |
December 31, 2018 | -299.96M |
September 30, 2018 | -312.31M |
June 30, 2018 | -228.45M |
March 31, 2018 | -213.37M |
December 31, 2017 | -213.70M |
Date | Value |
---|---|
September 30, 2017 | -172.26M |
June 30, 2017 | -164.23M |
March 31, 2017 | -155.05M |
December 31, 2016 | -150.15M |
September 30, 2016 | -154.06M |
June 30, 2016 | -134.20M |
March 31, 2016 | -124.10M |
December 31, 2015 | -100.14M |
September 30, 2015 | -79.14M |
June 30, 2015 | -73.24M |
March 31, 2015 | -62.42M |
December 31, 2014 | -51.67M |
September 30, 2014 | -45.28M |
June 30, 2014 | -43.67M |
March 31, 2014 | -42.11M |
December 31, 2013 | -45.79M |
September 30, 2013 | -45.05M |
June 30, 2013 | -38.74M |
March 31, 2013 | -39.60M |
December 31, 2012 | -33.74M |
September 30, 2012 | -38.89M |
June 30, 2012 | -44.68M |
March 31, 2012 | -44.16M |
December 31, 2011 | -49.42M |
September 30, 2011 | -14.54M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (TTM) Range, Past 5 Years
-330.47M
Minimum
Jun 2019
-69.09M
Maximum
Dec 2023
-198.98M
Average
-197.70M
Median
Mar 2021
Cash from Operations (TTM) Benchmarks
TG Therapeutics Inc | -31.41M |
Geron Corp | -167.74M |
Vanda Pharmaceuticals Inc | 12.80M |
Fate Therapeutics Inc | -132.26M |
Editas Medicine Inc | -132.18M |